![RNR RNR](https://data.pdbj.org/pdbjplus/data/cc/svg/RNR.svg) | RNR | Name: | 3,6-bis(3-(3'-(R)-fluoropyrrolindino)propionamido)acridine | Formula: | C27 H31 F2 N5 O2 | SMILES: | O=C(Nc4cc3nc2cc(NC(=O)CCN1CCC(F)C1)ccc2cc3cc4)CCN5CCC(F)C5 | InChi: | InChI=1S/C27H31F2N5O2/c28-20-5-9-33(16-20)11-7-26(35)30-22-3-1-18-13-19-2-4-23(15-25(19)32-24(18)14-22)31-27(36)8-12-34-10-6-21(29)17-34/h1-4,13-15,20-21H,5-12,16-17H2,(H,30,35)(H,31,36)/t20-,21-/m1/s1 | Synonyms: | N,N'-acridine-3,6-diylbis{3-[(3R)-3-fluoropyrrolidin-1-yl]propanamide} | Definition date: | 2010-07-27 | Last modified: | 2020-06-17 | Identifier: | N,N'-acridine-3,6-diylbis{3-[(3R)-3-fluoropyrrolidin-1-yl]propanamide} |
|
![RO0 RO0](https://data.pdbj.org/pdbjplus/data/cc/svg/RO0.svg) | RO0 | Name: | 1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXY-4-{[4-(2-METHOXYPHENYL)PIPERIDIN-1-YL]METHYL}ISOQUINOLINE | Formula: | C33 H38 N2 O5 | SMILES: | O(c1ccc(cc1OC)Cc3ncc(c2cc(OC)c(OC)cc23)CN5CCC(c4ccccc4OC)CC5)C | InChi: | InChI=1S/C33H38N2O5/c1-36-29-9-7-6-8-25(29)23-12-14-35(15-13-23)21-24-20-34-28(16-22-10-11-30(37-2)31(17-22)38-3)27-19-33(40-5)32(39-4)18-26(24)27/h6-11,17-20,23H,12-16,21H2,1-5H3 | Synonyms: | ISOQUINOLINE DERIVATIVE PA-082 | Definition date: | 2006-02-03 | Last modified: | 2020-06-17 | Identifier: | 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-4-{[4-(2-methoxyphenyl)piperidin-1-yl]methyl}isoquinoline |
|
![RPD RPD](https://data.pdbj.org/pdbjplus/data/cc/svg/RPD.svg) | RPD | Name: | (C8-R)-HYDANTOCIDIN 5'-PHOSPHATE | Formula: | C13 H22 N3 O13 P | SMILES: | O=C(O)C(N(O)CO)CCCN2C(=O)C1(OC(C(O)C1O)COP(=O)(O)O)NC2=O | InChi: | InChI=1S/C13H22N3O13P/c17-5-16(24)6(10(20)21)2-1-3-15-11(22)13(14-12(15)23)9(19)8(18)7(29-13)4-28-30(25,26)27/h6-9,17-19,24H,1-5H2,(H,14,23)(H,20,21)(H2,25,26,27)/t6-,7-,8-,9-,13+/m1/s1 | Synonyms: | [8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL]
PHOSPHATE | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | 5-{(5S,7R,8S,9R)-8,9-dihydroxy-2,4-dioxo-7-[(phosphonooxy)methyl]-6-oxa-1,3-diazaspiro[4.4]non-3-yl}-N-hydroxy-N-(hydroxymethyl)-D-norvaline |
|
![RPL RPL](https://data.pdbj.org/pdbjplus/data/cc/svg/RPL.svg) | RPL | Name: | (C8-S)-HYDANTOCIDIN 5'-PHOSPHATE | Formula: | C13 H22 N3 O13 P | SMILES: | O=C(O)C(N(O)CO)CCCN2C(=O)C1(OC(C(O)C1O)COP(=O)(O)O)NC2=O | InChi: | InChI=1S/C13H22N3O13P/c17-5-16(24)6(10(20)21)2-1-3-15-11(22)13(14-12(15)23)9(19)8(18)7(29-13)4-28-30(25,26)27/h6-9,17-19,24H,1-5H2,(H,14,23)(H,20,21)(H2,25,26,27)/t6-,7+,8+,9+,13-/m0/s1 | Synonyms: | [8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL]
PHOSPHATE | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | 5-{(5S,7R,8S,9R)-8,9-dihydroxy-2,4-dioxo-7-[(phosphonooxy)methyl]-6-oxa-1,3-diazaspiro[4.4]non-3-yl}-N-hydroxy-N-(hydroxymethyl)-L-norvaline |
|
![RUN RUN](https://data.pdbj.org/pdbjplus/data/cc/svg/RUN.svg) | RUN | Name: | 2-[(1R,3S,4S)-1-BENZYL-4-[N-(BENZYLOXYCARBONYL)-L-VALYL]AMINO-3-PHENYLPENTYL]-4(5)-(2-METHYLPROPIONYL)IMIDAZOLE | Formula: | C38 H46 N4 O5 | SMILES: | O=C(OCc1ccccc1)NC(C(=O)NC(C(O)CC(c2ncc(n2)C(=O)C(C)C)Cc3ccccc3)Cc4ccccc4)C(C)C | InChi: | InChI=1S/C38H46N4O5/c1-25(2)34(42-38(46)47-24-29-18-12-7-13-19-29)37(45)41-31(21-28-16-10-6-11-17-28)33(43)22-30(20-27-14-8-5-9-15-27)36-39-23-32(40-36)35(44)26(3)4/h5-19,23,25-26,30-31,33-34,43H,20-22,24H2,1-4H3,(H,39,40)(H,41,45)(H,42,46)/t30-,31+,33+,34+/m1/s1 | Synonyms: | SB206343 | Definition date: | 1999-07-08 | Last modified: | 2020-06-17 | Identifier: | N-{(1S,2S,4R)-1-benzyl-2-hydroxy-4-[5-(2-methylpropanoyl)-1H-imidazol-2-yl]-5-phenylpentyl}-N~2~-[(benzyloxy)carbonyl]-L-valinamide |
|
![RVI RVI](https://data.pdbj.org/pdbjplus/data/cc/svg/RVI.svg) | RVI | Name: | (2R)-2-{[2-amino-6-(2-methylphenyl)quinolin-3-yl]methyl}-N-(cyclohexylmethyl)pentanamide | Formula: | C29 H37 N3 O | SMILES: | O=C(NCC1CCCCC1)C(CCC)Cc2cc3cc(ccc3nc2N)c4ccccc4C | InChi: | InChI=1S/C29H37N3O/c1-3-9-23(29(33)31-19-21-11-5-4-6-12-21)17-25-18-24-16-22(14-15-27(24)32-28(25)30)26-13-8-7-10-20(26)2/h7-8,10,13-16,18,21,23H,3-6,9,11-12,17,19H2,1-2H3,(H2,30,32)(H,31,33)/t23-/m1/s1 | Synonyms: | 2-((2-Amino-6-o-tolylquinolin-3-yl)methyl)-N-(cyclohexylmethyl)pentanamide | Definition date: | 2011-05-10 | Last modified: | 2020-06-17 | Identifier: | (2R)-2-{[2-amino-6-(2-methylphenyl)quinolin-3-yl]methyl}-N-(cyclohexylmethyl)pentanamide |
|
![UVA UVA](https://data.pdbj.org/pdbjplus/data/cc/svg/UVA.svg) | UVA | Name: | N-methyl-2-(methylsulfonyl)aniline | Formula: | C8 H11 N O2 S | SMILES: | c1cc(S(C)(=O)=O)c(NC)cc1 | InChi: | InChI=1S/C8H11NO2S/c1-9-7-5-3-4-6-8(7)12(2,10)11/h3-6,9H,1-2H3 | Definition date: | 2020-06-02 | Last modified: | 2020-06-12 | Release date: | 2020-06-17 | Identifier: | N-methyl-2-(methylsulfonyl)aniline |
|
![UVM UVM](https://data.pdbj.org/pdbjplus/data/cc/svg/UVM.svg) | UVM | Name: | ethyl morpholine-4-carboxylate | Formula: | C7 H13 N O3 | SMILES: | C1OCCN(C(OCC)=O)C1 | InChi: | InChI=1S/C7H13NO3/c1-2-11-7(9)8-3-5-10-6-4-8/h2-6H2,1H3 | Definition date: | 2020-06-02 | Last modified: | 2020-06-12 | Release date: | 2020-06-17 | Identifier: | ethyl morpholine-4-carboxylate |
|
![UXJ UXJ](https://data.pdbj.org/pdbjplus/data/cc/svg/UXJ.svg) | UXJ | Name: | 2-fluoro-N-[(3-methyl-1H-pyrazol-4-yl)methyl]aniline | Formula: | C11 H12 F N3 | SMILES: | n2cc(CNc1ccccc1F)c(n2)C | InChi: | InChI=1S/C11H12FN3/c1-8-9(7-14-15-8)6-13-11-5-3-2-4-10(11)12/h2-5,7,13H,6H2,1H3,(H,14,15) | Definition date: | 2020-06-03 | Last modified: | 2020-06-12 | Release date: | 2020-06-17 | Identifier: | 2-fluoro-N-[(3-methyl-1H-pyrazol-4-yl)methyl]aniline |
|
![O7V O7V](https://data.pdbj.org/pdbjplus/data/cc/svg/O7V.svg) | O7V | Name: | (2R)-2-[(3S,4R,5E,10E,12E,14S,16R,26aR)-16-fluoro-14-hydroxy-4,12-dimethyl-1,7,22-trioxo-4,7,8,9,14,15,16,17,24,25,26,26a-dodecahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosin-3-yl]propyl isoquinolin-3-ylcarbamate | Formula: | C38 H44 F N5 O8 | SMILES: | C2(=CC(O)CC(Cc1nc(co1)C(N5C(C(OC(C(C=CC(NCC=C2)=O)C)C(C)COC(Nc3ncc4c(c3)cccc4)=O)=O)CCC5)=O)F)C | InChi: | InChI=1S/C38H44FN5O8/c1-23-8-6-14-40-33(46)13-12-24(2)35(25(3)21-51-38(49)43-32-17-26-9-4-5-10-27(26)20-41-32)52-37(48)31-11-7-15-44(31)36(47)30-22-50-34(42-30)19-28(39)18-29(45)16-23/h4-6,8-10,12-13,16-17,20,22,24-25,28-29,31,35,45H,7,11,14-15,18-19,21H2,1-3H3,(H,40,46)(H,41,43,49)/b8-6+,13-12+,23-16+/t24-,25-,28-,29-,31-,35+/m1/s1 | Definition date: | 2019-06-17 | Last modified: | 2020-06-12 | Release date: | 2020-06-17 | Identifier: | (2R)-2-[(3S,4R,5E,10E,12E,14S,16R,26aR)-16-fluoro-14-hydroxy-4,12-dimethyl-1,7,22-trioxo-4,7,8,9,14,15,16,17,24,25,26,26a-dodecahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosin-3-yl]propyl isoquinolin-3-ylcarbamate |
|
![O7Y O7Y](https://data.pdbj.org/pdbjplus/data/cc/svg/O7Y.svg) | O7Y | Name: | (2R)-2-[(3S,4R,5E,10E,12E,14S,26aR)-14-hydroxy-4,12-dimethyl-1,7,16,22-tetraoxo-4,7,8,9,14,15,16,17,24,25,26,26a-dodecahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosin-3-yl]propyl isoquinolin-3-ylcarbamate | Formula: | C38 H43 N5 O9 | SMILES: | C2(=CC(O)CC(Cc1nc(co1)C(N5C(C(OC(C(C=CC(NCC=C2)=O)C)C(C)COC(Nc3ncc4c(c3)cccc4)=O)=O)CCC5)=O)=O)C | InChi: | InChI=1S/C38H43N5O9/c1-23-8-6-14-39-33(46)13-12-24(2)35(25(3)21-51-38(49)42-32-17-26-9-4-5-10-27(26)20-40-32)52-37(48)31-11-7-15-43(31)36(47)30-22-50-34(41-30)19-29(45)18-28(44)16-23/h4-6,8-10,12-13,16-17,20,22,24-25,28,31,35,44H,7,11,14-15,18-19,21H2,1-3H3,(H,39,46)(H,40,42,49)/b8-6+,13-12+,23-16+/t24-,25-,28-,31-,35+/m1/s1 | Definition date: | 2019-06-17 | Last modified: | 2020-06-12 | Release date: | 2020-06-17 | Identifier: | (2R)-2-[(3S,4R,5E,10E,12E,14S,26aR)-14-hydroxy-4,12-dimethyl-1,7,16,22-tetraoxo-4,7,8,9,14,15,16,17,24,25,26,26a-dodecahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosin-3-yl]propyl isoquinolin-3-ylcarbamate |
|
![O8V O8V](https://data.pdbj.org/pdbjplus/data/cc/svg/O8V.svg) | O8V | Name: | (2S)-2-[(3S,4R,5E,10E,12E,14S,26aR)-14-hydroxy-4,12-dimethyl-1,7,16,22-tetraoxo-4,7,8,9,14,15,16,17,24,25,26,26a-dodecahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosin-3-yl]propyl isoquinolin-3-ylcarbamate | Formula: | C38 H43 N5 O9 | SMILES: | C4(O)C=C(C=CCNC(C=CC(C)C(C(C)COC(=O)Nc1ncc2c(c1)cccc2)OC(C3CCCN3C(c5coc(CC(C4)=O)n5)=O)=O)=O)C | InChi: | InChI=1S/C38H43N5O9/c1-23-8-6-14-39-33(46)13-12-24(2)35(25(3)21-51-38(49)42-32-17-26-9-4-5-10-27(26)20-40-32)52-37(48)31-11-7-15-43(31)36(47)30-22-50-34(41-30)19-29(45)18-28(44)16-23/h4-6,8-10,12-13,16-17,20,22,24-25,28,31,35,44H,7,11,14-15,18-19,21H2,1-3H3,(H,39,46)(H,40,42,49)/b8-6+,13-12+,23-16+/t24-,25+,28-,31-,35+/m1/s1 | Definition date: | 2019-06-18 | Last modified: | 2020-06-12 | Release date: | 2020-06-17 | Identifier: | (2S)-2-[(3S,4R,5E,10E,12E,14S,26aR)-14-hydroxy-4,12-dimethyl-1,7,16,22-tetraoxo-4,7,8,9,14,15,16,17,24,25,26,26a-dodecahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosin-3-yl]propyl isoquinolin-3-ylcarbamate |
|
![GNJ GNJ](https://data.pdbj.org/pdbjplus/data/cc/svg/GNJ.svg) | GNJ | Name: | 4-hydroxy-8-sulfoquinoline-3-carboxylic acid | Formula: | C10 H7 N O6 S | SMILES: | c1c(c2ncc(c(c2cc1)O)C(=O)O)S(O)(=O)=O | InChi: | InChI=1S/C10H7NO6S/c12-9-5-2-1-3-7(18(15,16)17)8(5)11-4-6(9)10(13)14/h1-4H,(H,11,12)(H,13,14)(H,15,16,17) | Definition date: | 2018-05-30 | Last modified: | 2020-06-01 | Release date: | 2019-05-29 | Identifier: | 4-hydroxy-8-sulfoquinoline-3-carboxylic acid |
|
![8C1 8C1](https://data.pdbj.org/pdbjplus/data/cc/svg/8C1.svg) | 8C1 | Name: | 4-{[(3R)-piperidin-3-yl]oxy}-6-[(propan-2-yl)oxy]quinoline-7-carboxamide | Formula: | C18 H23 N3 O3 | SMILES: | c21cc(OC(C)C)c(cc1nccc2OC3CCCNC3)C(N)=O | InChi: | InChI=1S/C18H23N3O3/c1-11(2)23-17-9-13-15(8-14(17)18(19)22)21-7-5-16(13)24-12-4-3-6-20-10-12/h5,7-9,11-12,20H,3-4,6,10H2,1-2H3,(H2,19,22)/t12-/m1/s1 | Definition date: | 2017-01-18 | Last modified: | 2020-06-01 | Release date: | 2017-05-24 | Identifier: | 4-{[(3R)-piperidin-3-yl]oxy}-6-[(propan-2-yl)oxy]quinoline-7-carboxamide |
|
![U64 U64](https://data.pdbj.org/pdbjplus/data/cc/svg/U64.svg) | U64 | Name: | 6-[(Z)-2-{3-[(1S,5S,6S)-3-amino-5-methyl-1-(morpholine-4-carbonyl)-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4-fluorophenyl}-1-fluoroethenyl]pyridine-3-carbonitrile | Formula: | C25 H23 F2 N5 O2 S | SMILES: | c4(cc(C1(C)C2C(SC(=N1)N)(C2)C(=O)N3CCOCC3)c(F)cc4)[C@H]=C(F)c5ccc(cn5)C#N | InChi: | InChI=1S/C25H23F2N5O2S/c1-24(21-12-25(21,35-23(29)31-24)22(33)32-6-8-34-9-7-32)17-10-15(2-4-18(17)26)11-19(27)20-5-3-16(13-28)14-30-20/h2-5,10-11,14,21H,6-9,12H2,1H3,(H2,29,31)/b19-11-/t21-,24+,25-/m0/s1 | Definition date: | 2020-04-27 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | 6-[(Z)-2-{3-[(1S,5S,6S)-3-amino-5-methyl-1-(morpholine-4-carbonyl)-2-thia-4-azabicyclo[4.1.0]hept-3-en-5-yl]-4-fluorophenyl}-1-fluoroethenyl]pyridine-3-carbonitrile |
|
![E5V E5V](https://data.pdbj.org/pdbjplus/data/cc/svg/E5V.svg) | E5V | Name: | (4S)-4-{(S)-hydroxy[(3R,6R)-6-(methoxymethyl)morpholin-3-yl]methyl}-19-(methoxymethyl)-11-oxa-3,16-diazatricyclo[15.3.1.1~6,10~]docosa-1(21),6(22),7,9,17,19-hexaen-2-one | Formula: | C28 H39 N3 O6 | SMILES: | COCC4OCC(C(C2Cc3cccc(OCCCCNc1cc(COC)cc(c1)C(N2)=O)c3)O)NC4 | InChi: | InChI=1S/C28H39N3O6/c1-34-16-20-10-21-14-22(11-20)29-8-3-4-9-36-23-7-5-6-19(12-23)13-25(31-28(21)33)27(32)26-18-37-24(15-30-26)17-35-2/h5-7,10-12,14,24-27,29-30,32H,3-4,8-9,13,15-18H2,1-2H3,(H,31,33)/t24-,25+,26-,27+/m1/s1 | Definition date: | 2017-12-04 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | (4S)-4-{(S)-hydroxy[(3R,6R)-6-(methoxymethyl)morpholin-3-yl]methyl}-19-(methoxymethyl)-11-oxa-3,16-diazatricyclo[15.3.1.1~6,10~]docosa-1(21),6(22),7,9,17,19-hexaen-2-one |
|
![LQ8 LQ8](https://data.pdbj.org/pdbjplus/data/cc/svg/LQ8.svg) | LQ8 | Name: | (1~{S},2~{R})-2-[[(1~{S})-1-[[1,3-bis(oxidanylidene)isoindol-2-yl]methyl]-5-(2-hydroxyethyloxy)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]cyclohexane-1-carboxylic acid | Formula: | C28 H30 N2 O7 | SMILES: | OCCOc1cccc2[CH](CN3C(=O)c4ccccc4C3=O)N(CCc12)C(=O)[CH]5CCCC[CH]5C(O)=O | InChi: | InChI=1S/C28H30N2O7/c31-14-15-37-24-11-5-10-17-18(24)12-13-29(25(32)21-8-3-4-9-22(21)28(35)36)23(17)16-30-26(33)19-6-1-2-7-20(19)27(30)34/h1-2,5-7,10-11,21-23,31H,3-4,8-9,12-16H2,(H,35,36)/t21-,22+,23-/m1/s1 | Definition date: | 2019-08-30 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | (1~{S},2~{R})-2-[[(1~{S})-1-[[1,3-bis(oxidanylidene)isoindol-2-yl]methyl]-5-(2-hydroxyethyloxy)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]cyclohexane-1-carboxylic acid |
|
![LQK LQK](https://data.pdbj.org/pdbjplus/data/cc/svg/LQK.svg) | LQK | Name: | (1~{S},2~{R})-2-[[(1~{S})-1-[[1,3-bis(oxidanylidene)isoindol-2-yl]methyl]-5-(2-hydroxyethyloxy)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]cyclobutane-1-carboxamide | Formula: | C26 H27 N3 O6 | SMILES: | NC(=O)[CH]1CC[CH]1C(=O)N2CCc3c(OCCO)cccc3[CH]2CN4C(=O)c5ccccc5C4=O | InChi: | InChI=1S/C26H27N3O6/c27-23(31)17-8-9-20(17)24(32)28-11-10-16-15(6-3-7-22(16)35-13-12-30)21(28)14-29-25(33)18-4-1-2-5-19(18)26(29)34/h1-7,17,20-21,30H,8-14H2,(H2,27,31)/t17-,20+,21+/m0/s1 | Definition date: | 2019-08-30 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | (1~{S},2~{R})-2-[[(1~{S})-1-[[1,3-bis(oxidanylidene)isoindol-2-yl]methyl]-5-(2-hydroxyethyloxy)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]cyclobutane-1-carboxamide |
|
![K75 K75](https://data.pdbj.org/pdbjplus/data/cc/svg/K75.svg) | K75 | Name: | (8~{R})-~{N}2-methyl-8-prop-1-ynyl-7,8-dihydro-3~{H}-imidazo[4,5-g]quinazoline-2,6-diamine | Formula: | C13 H14 N6 | SMILES: | CNc1[nH]c2cc3N=C(N)N[CH](C#CC)c3cc2n1 | InChi: | InChI=1S/C13H14N6/c1-3-4-8-7-5-10-11(19-13(15-2)18-10)6-9(7)17-12(14)16-8/h5-6,8H,1-2H3,(H3,14,16,17)(H2,15,18,19)/t8-/m1/s1 | Definition date: | 2019-05-01 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | (8~{R})-~{N}2-methyl-8-prop-1-ynyl-7,8-dihydro-3~{H}-imidazo[4,5-g]quinazoline-2,6-diamine |
|
![K7H K7H](https://data.pdbj.org/pdbjplus/data/cc/svg/K7H.svg) | K7H | Name: | ~{N}2-methyl-7,8-dihydro-3~{H}-imidazo[4,5-g]quinazoline-2,6-diamine | Formula: | C10 H12 N6 | SMILES: | CNc1[nH]c2cc3N=C(N)NCc3cc2n1 | InChi: | InChI=1S/C10H12N6/c1-12-10-15-7-2-5-4-13-9(11)14-6(5)3-8(7)16-10/h2-3H,4H2,1H3,(H3,11,13,14)(H2,12,15,16) | Definition date: | 2019-05-01 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | ~{N}2-methyl-7,8-dihydro-3~{H}-imidazo[4,5-g]quinazoline-2,6-diamine |
|
![F0C F0C](https://data.pdbj.org/pdbjplus/data/cc/svg/F0C.svg) | F0C | Name: | 1-[(4-methoxyphenyl)methyl]-3,4,5,6,7,8-hexahydroisoquinoline | Formula: | C17 H21 N O | SMILES: | COc1ccc(CC2=NCCC3=C2CCCC3)cc1 | InChi: | InChI=1S/C17H21NO/c1-19-15-8-6-13(7-9-15)12-17-16-5-3-2-4-14(16)10-11-18-17/h6-9H,2-5,10-12H2,1H3 | Definition date: | 2020-03-02 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | 1-[(4-methoxyphenyl)methyl]-3,4,5,6,7,8-hexahydroisoquinoline |
|
![O3H O3H](https://data.pdbj.org/pdbjplus/data/cc/svg/O3H.svg) | O3H | Name: | 2-[2-(4-pyridin-2-ylpiperazin-1-yl)ethylsulfanyl]-3~{H}-quinazolin-4-one | Formula: | C19 H21 N5 O S | SMILES: | O=C1NC(=Nc2ccccc12)SCCN3CCN(CC3)c4ccccn4 | InChi: | InChI=1S/C19H21N5OS/c25-18-15-5-1-2-6-16(15)21-19(22-18)26-14-13-23-9-11-24(12-10-23)17-7-3-4-8-20-17/h1-8H,9-14H2,(H,21,22,25) | Definition date: | 2020-01-22 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | 2-[2-(4-pyridin-2-ylpiperazin-1-yl)ethylsulfanyl]-3~{H}-quinazolin-4-one |
|
![Q8W Q8W](https://data.pdbj.org/pdbjplus/data/cc/svg/Q8W.svg) | Q8W | Name: | 10-(2-morpholin-4-ylethyl)-7-oxa-10,13,17,18,21-pentazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene | Formula: | C22 H26 N6 O2 | SMILES: | C1CN(CCN2CCOCC2)C=COc3cccc(c3)c4cnn5C=CC(=Nc45)N1 | InChi: | InChI=1S/C22H26N6O2/c1-2-18-16-19(3-1)30-15-12-26(8-9-27-10-13-29-14-11-27)7-5-23-21-4-6-28-22(25-21)20(18)17-24-28/h1-4,6,12,15-17H,5,7-11,13-14H2,(H,23,25)/b15-12+ | Definition date: | 2020-05-26 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 |
|
![R9Y R9Y](https://data.pdbj.org/pdbjplus/data/cc/svg/R9Y.svg) | R9Y | Name: | 1-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)methanamine | Formula: | C11 H16 N2 | SMILES: | c12cc(ccc1N(CCC2)C)CN | InChi: | InChI=1S/C11H16N2/c1-13-6-2-3-10-7-9(8-12)4-5-11(10)13/h4-5,7H,2-3,6,8,12H2,1H3 | Definition date: | 2020-02-10 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | 1-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)methanamine |
|
![RN7 RN7](https://data.pdbj.org/pdbjplus/data/cc/svg/RN7.svg) | RN7 | Name: | 2-[(4-amino-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(morpholin-4-yl)ethyl]acetamide | Formula: | C18 H25 N5 O2 S2 | SMILES: | C3Cc2c1c(N)nc(nc1sc2CC3)SCC(NCCN4CCOCC4)=O | InChi: | InChI=1S/C18H25N5O2S2/c19-16-15-12-3-1-2-4-13(12)27-17(15)22-18(21-16)26-11-14(24)20-5-6-23-7-9-25-10-8-23/h1-11H2,(H,20,24)(H2,19,21,22) | Definition date: | 2020-02-17 | Last modified: | 2020-05-29 | Release date: | 2020-06-03 | Identifier: | 2-[(4-amino-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(morpholin-4-yl)ethyl]acetamide |
|